✦ LIBER ✦

Small Molecule Targeted Therapies for the Second Line Treatment of Metastatic Renal Cell Carcinoma (mRCC): A Systematic Review and Indirect Comparison of Safety and Efficacy

✍ Scribed by Dranitsaris, G.; Schmitz, S.; Broom, R.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Small molecule targeted therapies for th

✍ Dranitsaris, George; Schmitz, Susanne; Broom, Reuben J. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 325 KB

Sunitinib and bevacizumab for first-line

✍ Thompson Coon, J S; Liu, Z; Hoyle, M; Rogers, G; Green, C; Moxham, T; Welch, K; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Economic evaluation of new targeted ther

✍ Ágnes Benedict; Robert A. Figlin; Per Sandström; Ulrika Harmenberg; Anders Ullén 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

PCN16 MIXED TREATMENT COMPARISON OF BEVA

✍ Y Yi; C Chouaid; A Vergnenegre; HG Bischoff; G Bergman; S Walzer; Z Philips 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Efficacy of everolimus in second- and th

✍ Buchler, Tomas; Bortlicek, Zbynek; Poprach, Alexandr; Kubackova, Katerina; Kiss, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 327 KB